Thiazolidinediones, Cardiovascular Disease and Cardiovascular Mortality: Translating Research Into Action For Diabetes (TRIAD)

BACKGROUND: Studies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (CVD) and questioned whether the two available TZDs, rosiglitazone and pioglitazone, have different CVD risks. We compared CVD incidence, cardiovascular (CV) and all-cause mortality in type 2 diabetic p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Bilik, Dori, McEwen, Laura N., Brown, Morton B., Selby, Joe V., Karter, Andrew J., Marrero, David G., Hsiao, Victoria C., Tseng, Chien-Wen, Mangione, Carol M., Lasser, Norman L., Crosson, Jesse C., Herman, William H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2010
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3548906/
https://ncbi.nlm.nih.gov/pubmed/20583206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pds.1954
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg